References
- Nekkanti V, Rueda J, Wang Z, et al. Design, characterization, and in vivo pharmacokinetics of tacrolimus proliposomes. AAPS Pharm SciTech. 2016;17(5):1019–1029.
- Hiremath S, Soppimath S, Betageri V. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine. Int J Pharm. 2009;380(1-2):96–104.
- Katare P, Vyas P, Dixit K. Effervescent granule based proliposomes of ibuprofen. J Microencapsul. 1990;7(4):455–462.
- Nekkanti V, Venkatesan N, Betageri GV. Proliposomes for oral delivery: progress and challenges. CPB. 2015;16(4):303–312.
- Nekkanti V, Venkatesan N, Wang Z, et al. Improved oral bioavailability of valsartan using pro-liposomes: design, characterization and in vivo pharmacokinetics. Drug Dev Ind Pharm. 2015;41(12):2077–2088.
- Patel M, Shelat K, Lalwani N. QbD based development of proliposome of lopinavir for improved oral bioavailability. Eur J Pharm Sci. 2017;108:50–61.
- Bhalekar M, Upadhaya P, Madgulkar A. Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug darunavir. Appl Nanosci. 2017;7(1-2):47–57.
- Rehman S, Nabi B, Fazil M, et al. Role of P-glycoprotein inhibitors in the bioavailability enhancement of solid dispersion of darunavir. BioMed Res Int. 2017;2017:1–17.
- Dixit R, Mathur B. Formulation and characterization of solid microemulsion of darunavir for enhanced solubility and dissolution. Int J Pharm Sci Res. 2015;6:3990–3999.
- Bhalekar R, Upadhaya G, Madgulkar R, et al. In-vivo bioavailability and lymphatic uptake evaluation of lipid nanoparticulates of darunavir. Drug Deliv. 2015;23:1– 2586.
- Janga Y, Jukanti R, Velpula A, et al. Bioavailability enhancement of zaleplon via proliposomes: role of surface charge. Eur J Pharm Biopharm. 2012;80(2):347–357.
- Abul Kalam M, Khan AA, Khan S, et al. Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box–Behnken experimental design. Int J Biol Macromol. 2016;87:329–340.
- Gannu R, Yamsani V, Yamsani K, et al. Optimization of hydrogels for transdermal delivery of lisinopril by Box–Behnken statistical design. AAPS Pharm Sci Tech. 2009;10(2):505–514.
- Nalla P, Bagam S, Eedara B, et al. Formulation and evaluation of domperidone oral proliposomal powders. Int J PharmTech Res. 2014;7:108–118.
- Jukanti R, Sheela S, Bandari S, et al. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery. J Pharm Sci. 2011;100(8):3208–3222.
- Bobbala K, Veerareddy R. Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery. J Liposome Res. 2012;22(4):285–294.
- Karn R, Jin S, Lee J, et al. Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method. Int J Nanomedicine. 2014;9:5079–5091.
- Devamani H, Deepa N, Gayathri J. Morphology and thermal studies of calcium carbonate nanoparticles. IJIRSET. 2016;3:87–89.
- Devamani H, Krishnaveni M, Rose M. Morphology and thermal studies of nickel carbonate nanoparticles. IJSTM. 2016;5:85–89.
- Gupta V, Barupal K, Ramteke S. Formulation development and in vitro characterization of proliposomes for topical delivery of aceclofenac. Ind J Pharm Sci. 2008;70(6):768–775.
- Mudit D, Kulkarni K, Selvam P, et al. Preparation and characterization of freeze dried crystals of ibuprofen. IRJP. 2011;2:255–258.
- Karn R, Cho W, Park H, et al. Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method. Int J Nanomed. 2013;8:365–377.
- Attari Z, Bhandari A, Jagadish C, et al. Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: preparation by combinative technology. Saudi Pharm J. 2016;24(1):57–63.
- Sallam A, Bosca T. Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication. Int J Nanomed. 2015;10:4459–4478.
- Ghosh K, Majithiya J, Umrethia L, et al. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS Pharm Sci Tech. 2006;7:E1–E6.